Ryan Coller, MD, MPH, Wins 2017 Odell Research Award
Ryan Coller, MD, MPH, has been awarded the 2017 UW Department of Pediatrics Gerard B. Odell Research Award. This award was established in 1994 to honor Dr. Odell's distinguished career in pediatric research, academia, clinical practice and education. The $5,000 award is given to an assistant or associate Professor in the Department of Pediatrics in recognition of outstanding research accomplishments and demonstrated potential for future contributions. Most recent past recipients include: Drs. Elizabeth Cox, Theresa Guilbert, Daniel Jackson, Megan Moreno, J. Carter Ralphe, and Judith Smith. Dr. Coller will receive the award at the May 18, 2017 Odell Lecture, which will be given by J. Carter Ralphe, the 2015 Odell Awardee.
Research & Development Committee Awards Announced
The Department of Pediatrics Research and Development Committee recently awarded grants to six faculty members for the following projects:
- Awni Al-Subu, MD - UW Pediatric Critical Care Point-of-Care Ultrasound Program
- Pelin Cengiz, MD - Epigenetic Regulation of Estrogen Receptor Alpha after Neonatal Hypoxia Ischemia
- Pamela Kling, MD - Improving the Sensitivity & Specificity of Iron Deficiency Screening of Newborns
- Luke Lamers, MD - Feasibility of Stent Expansion in a Swine Model of Branch PA Stenosis
- Amy Peterson, MD - Joint Database for Pediatric Metabolic Syndrome and Preventive Cardiology Clinics
- Sarah Webber, MD - Community Health Worker Led Postpartum Support Group for Latino Mothers & Infants
Additionally, nine laboratories/investigators were awarded Capital Equipment Funding:
- Elizabeth Cox, MD, PhD
- Marlowe Eldridge, MD
- Allergy Researchers (Drs. Busse, Gern, Jackson, Lemanske, Seroogy, and Smith)
- Anna Huttenlocher, MD
- Bruce Klein, MD
- Pamela Kling, MD
- Bikash Pattnaik, PhD
- Paul Sondel, MD, PhD
- Christine Sorenson, PhD
Nathaniel York Awarded ERP Student Research Grant
Nathaniel York, graduate student in the laboratory of Bikash Pattnaik, PhD, was recently awarded a one-year Endocrinology and Reproductive Physiology Program (ERP) Student Research Grant from the University of Wisconsin School of Medicine and Public Health in the amount of $3,000, for his project "Characterization of Oxytocin Receptor in the RPE." Pattnaik Laboratory findings have recently demonstrated the localization of oxytocin (OXT) to the outer segments of the cone photoreceptors. Moreover, the oxytocin receptor is expressed in the retinal pigment epithelium (RPE), suggesting that oxytocinergic signaling is a potential means for communication between cone photoreceptors and the RPE. Based on these findings, Nathan has developed a project focused on describing the signaling of OXT in the RPE as well as characterizing the expression of oxytocin receptor in the retina. Congratulations, Nathan!
Ellen Connor, MD, Voted NASPAG President Elect and President
Ellen Connor, MD, was recently selected as President Elect of the North American Society for Pediatric and Adolescent Gynecology (NASPAG). Her role as President elect will run from April 2017 until March 2018, then she will become President from April 2018 through April 2019, coordinating monthly Board calls and coordinating/presiding over the NASPAG annual research meeting in April 2018, and then serve as Past President beginning in 2019. Congratulations to Ellen for this important honor!
Halie Anderson, MD, Receives Abstract Award from AAAAI
Congratulations to Halie Anderson, MD, second-year allergy and immunology fellow, for receiving the Asthma Diagnosis & Treatment Interest Section Fellow-in-Training Outstanding Abstract Award at the American Academy of Allergy Asthma and Immunology (AAAAI) annual meeting March 3-6, 2017 in Atlanta, GA. Her abstract entitled "Increased rhinovirus-induced innate immune response in peripheral blood during infancy is associated with improved lung function at school age" evaluated potential factors critical to antiviral immunity and lung growth in children. Her abstract was also selected for the featured poster session of the AAAAI. Dr. Anderson's mentor for the project is Daniel Jackson, MD.
Daniel Jackson, MD, Awarded Burton Zweiman Memorial Lectureship
Daniel Jackson, MD, was awarded the Burton Zweiman Memorial Lectureship at the American Academy of Allergy Asthma and Immunology (AAAAI) annual meeting in Atlanta, GA on March 5th, 2017. This honorary AAAAI lectureship was presented to Dr. Jackson in recognition of his outstanding service to the specialty and science of allergy and immunology. The lecture was "Targeting Viruses in the Primary and Secondary Prevention of Asthma."
Marcel Wüethrich, PhD, Awarded UW Technology Innovation Fund Grant
UW-Madison Technology Innovation Fund has awarded a $50,000 grant to Marcel Wüethrich, PhD, for this project entitled, "BI-Eng3- an adjuvant for vaccine prevention of global pathogens." This one-year award will extend his lab findings in pre-clinical work to influenza A virus and tuberculosis by using models of experimental infection. Congratulations, Marcel!
Meet Our New Interns!
Bruce Klein, MD, Awarded R21 from NIHPosted: February 2017
Bruce Klein, MD, recently received a new R21 award in the amount of $408,030 for his project entitled, "Hybrid histidine kinase: a drug target and path to anti-fungal drug development". In this 2-year grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID), Dr. Klein and his team propose to discover the mode of action of anti-fungal drugs that require group III hybrid histidine kinases (HHKs). HHKs regulate the HOG (high-osmolarity glycerol) pathway and are conserved in fungi and absent in mammals, making them an ideal drug target. Fungicides that require the HOG pathway to kill pathogens are used in agriculture, but are too toxic for use in human patients. The drug target of these agricultural fungicides is unclear and represents a gap in our knowledge with significant implications. An understanding of the actual drug target will unveil a new path to antifungal drug development for patients. Congratulations, Bruce!
Daniel Jackson, MD, Leads New NIH Asthma Study with Boston InvestigatorsPosted: February 2017
Congratulations to Daniel Jackson, MD for receiving funding for a consortium led by Children's Hospital of Boston. The group will initiate an asthma prevention study entitled, "Controlling and Preventing Asthma Severity in Kids" (CASK). The study will determine whether omalizumab (anti-IgE) therapy given to 2- and 3-year-old children at high risk for asthma based upon having allergies and wheezing will prevent the progression to childhood asthma. This 7-year, U01 grant funded by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID), includes a subcontract to UW-Madison totaling over $2 million.